INTCO MEDICAL(SZ:300677) Sou Hu Cai Jing·2025-08-08 09:42Core Viewpoint - The company Inke Medical is experiencing a decline in stock price and has a lower price-to-earnings (PE) ratio compared to the industry average, indicating potential undervaluation in the medical device sector [1][2]. Company Summary - Inke Medical's stock closed at 37.58 yuan, down 2.19%, with a rolling PE ratio of 15.57 times and a total market capitalization of 24.603 billion yuan [1]. - The company specializes in the research, production, and sales of high-performance personal protective products, including disposable nitrile gloves, PVC gloves, isolation gowns, masks, and various medical equipment [1]. - For Q1 2025, Inke Medical reported revenue of 2.494 billion yuan, a year-on-year increase of 13.20%, and a net profit of 353 million yuan, reflecting a year-on-year growth of 48.08% with a gross profit margin of 24.16% [1]. Industry Summary - The average PE ratio for the medical device industry is 55.70 times, with a median of 39.08 times, positioning Inke Medical at the 33rd rank within the industry [1][2]. - The industry shows a significant variation in PE ratios, with other companies like Jiuan Medical at 11.14 times and Shandong Pharmaceutical Glass at 16.06 times, indicating a diverse valuation landscape [2].